01 5Sulperazon
Main Therapeutic Indication : Nephrology
Currency : USD
2019 Revenue in Millions : 684
2018 Revenue in Millions : 613
Growth (%) : 12
Main Therapeutic Indication : Nephrology
Currency : USD
2020 Revenue in Millions : 618
2019 Revenue in Millions : 684
Growth (%) : -10
Main Therapeutic Indication : Nephrology
Currency : USD
2021 Revenue in Millions : 683
2020 Revenue in Millions : 618
Growth (%) : 11
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2022 Revenue in Millions : 786
2021 Revenue in Millions : 683
Growth (%) : 15
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2023 Revenue in Millions : 757
2022 Revenue in Millions : 786
Growth (%) : -4
LOOKING FOR A SUPPLIER?